{'fraction_non_alphanumeric': 0.06342088404868675, 'fraction_numerical': 0.03971812940422806, 'mean_word_length': 4.721611721611722, 'pattern_counts': {'":': 0, '<': 5, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Cerebral non‐oxidative carbohydrate consumption in humans driven by adrenaline

During brain activation, the decrease in the ratio between cerebral oxygen and carbohydrate uptake (6 O2/(glucose +1/2 lactate); the oxygen–carbohydrate index, OCI) is attenuated by the non‐selective β‐adrenergic receptor antagonist propranolol, whereas OCI remains unaffected by the β1‐adrenergic receptor antagonist metroprolol. These observations suggest involvement of a β2‐adrenergic mechanism in non‐oxidative metabolism for the brain. Therefore, we evaluated the effect of adrenaline (0.08 μg kg−1 min−1i.v. for 15 min) and noradrenaline (0.5, 0.1 and 0.15 μg kg−1 min−1i.v. for 20 min) on the arterial to internal jugular venous concentration differences (a‐v diff) of O2, glucose and lactate in healthy humans. Adrenaline (n= 10) increased the arterial concentrations of O2, glucose and lactate (P < 0.05) and also increased the a‐v diff for glucose from 0.6 ± 0.1 to 0.8 ± 0.2 mm (mean ±s.d.; P < 0.05). The a‐v diff for lactate shifted from a net cerebral release to an uptake and OCI was lowered from 5.1 ± 1.5 to 3.6 ± 0.4 (P < 0.05) indicating an 8‐fold increase in the rate of non‐oxidative carbohydrate uptake during adrenaline infusion (P < 0.01). Conversely, noradrenaline (n= 8) did not affect the OCI despite an increase in the a‐v diff for glucose (P < 0.05). These results support that non‐oxidative carbohydrate consumption for the brain is driven by a β2‐adrenergic mechanism, giving neurons an abundant provision of energy when plasma adrenaline increases.